novartis_rm_logo_pos_rgb.png
Leqvio-logo-UK+triangle_rgb_4c (1).jpg

Novartis UK Webinar 

Introducing inclisiran
in your region:
How to take a Population Health Management approach to lipid management

This promotional meeting is organised and funded by Novartis Pharmaceuticals UK Ltd.

UK | February 2022 | 189786

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.UK/yellowcard.

Adverse events should also be reported to Novartis via uk.patientsafety@novartis.com or online through the pharmacovigilance intake (PVI) tool at www.report.novartis.com.

If you have a question about the product, please contact Medical Information on 01276 698370 or by email at medinfo.uk@novartis.com

To learn about your data privacy rights and the use of your personal information, we invite you to read our General Privacy Notice for Business Partners.